Julie Seiffert

Ms. Seiffert is the Senior Vice President, of Manufacturing and Compliance at Équilibre Biopharmaceutical Corp. Prior to joining Équilibre, Ms. Seiffert held Quality, Manufacturing, and Compliance roles at Kadmon Corporation. This included the development of GxP compliant processes that controlled the quality of manufacturing and clinical trial activities and implementation information systems. She has expertise in both clinical and commercial quality and product development and was involved in the inspection and approval of REZUROCK by the FDA, as well as the subsequent acquisition by Sanofi. Prior to this, she spent 12 years at GlaxoSmithKline.

Ms. Seiffert holds a Master of Business Administration and Bachelor of Science degree in Biological Sciences from the University of Pittsburgh.